CSL Limited (CMXHF)
OTCMKTS · Delayed Price · Currency is USD
150.82
+2.80 (1.89%)
Aug 21, 2025, 1:09 PM EDT
CSL Limited Market Cap
CSL Limited has a market cap or net worth of $70.42 billion as of August 21, 2025. Its market cap has decreased by -27.40% in one year.
Market Cap
70.42B
Enterprise Value
81.63B
Revenue
15.56B
Ranking
n/a
PE Ratio
23.46
Stock Price
$150.82
Market Cap Chart
Since June 2, 1994, CSL Limited's market cap has increased from 230.16M to 70.42B, an increase of 30,497.86%. That is a compound annual growth rate of 20.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 20, 2025 | 68.78B | -18.48% |
| Dec 31, 2024 | 84.38B | -10.61% |
| Dec 29, 2023 | 94.40B | 0.09% |
| Dec 30, 2022 | 94.31B | -6.81% |
| Dec 31, 2021 | 101.20B | 1.81% |
| Dec 31, 2020 | 99.40B | 13.04% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 815.18M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 610.45M |
| Glass House Brands | 554.44M |
| Nika Pharmaceuticals | 453.04M |
| American Oncology Network | 385.65M |
| CytoDyn | 365.94M |
| Northwest Biotherapeutics | 355.76M |